Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation

NCT02831894 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT02831894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02831894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation
Lead sponsor
National Jewish Health
Phase
Phase 2
Overall status
Completed
Start date
November 2, 2015
Completion date
June 30, 2019
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypnotic dependence among those with insomnia